SOURCE-LINKED STUDY SUMMARY
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.
Abstract summarizedQuality not appraised
- What was studied
- A retrospective chart review explored reported knee-pain relief after BPC 157, alone or with thymosin-beta-4 (TB4). This was not a randomized treatment comparison.
- Who / model studied
- Seventeen patients were included at one Florida practice; 16 were reached by phone. Most injections occurred 6 months to 1 year before the review.
- Studied dose & schedule
- Twelve patients received intra-articular BPC 157 alone; four received BPC 157 with TB4. The supplied abstract does not report drug amounts or a dosing schedule.
- What the study found
- Pain improvement was reported by 11 of 12 BPC-only patients and 75% of combination recipients; overall, 14 of 16 reported relief. These reports do not establish tissue regeneration.
- Limitations & context
- Follow-up varied, and no specific tools measured function, quality of life, stiffness, or daily activities. Retrospective patient reports cannot establish treatment effectiveness.
Read summary source ↗ · Prepared 9/24/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.